The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites
Ivacaftor–lumacaftor and ivacaftor are two new breakthrough cystic fibrosis transmembrane conductance modulators. The interactions of ivacaftor and its two metabolites hydroxymethylivacaftor (iva-M1) and ivacaftorcarboxylate (iva-M6) with neurotransmitter receptors were investigated in radioligand b...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2018-03-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/4/1/00127-2017.full |